Dr. Nils Grosse Hokamp shares his experience of using mint Lesion™ at the University Hospital Cologne in this brief interview. He talks about how they have expanded their usage of mint Lesion™ over the years, how it has changed their clinical studies, and his view on the potential of structured data for research.
Potential of using structured data from clinical trials and routine for AI and radiomics research
Related Resources

Lung cancer screening: cooperation for efficient processes and digital networking
Heidelberg, September 15, 2026 – In close collaboration with two second-reader centers in Heidelberg and 25 outpatient radiology screening providers,…
Read more

Predicting hepatocellular carcinoma (HCC) before it develops: Artificial Intelligence meets MRI
At RÖKO 2026, we spoke with Prof. Dr. Timm Denecke, Director of Radiology at Leipzig University Hospital, about RACOON-MARDER, a research project…
Read more

AI-Powered Whole-Body MRI for Multiple Myeloma: Interview with Prof. Christina Messiou
Multiple myeloma poses a unique challenge for radiologists: the disease often affects the bone marrow unevenly, and conventional biopsies can only…
Read more
